More articles from Diabetes and the Kidney

You have accessRestricted Access
Carbamylated Lipoproteins and Progression of Diabetic Kidney Disease
Kathryn C.B. Tan, Ching-Lung Cheung, Alan C.H. Lee, Joanne K.Y. Lam, Ying Wong and Sammy W.M. Shiu

CJASN March 2020, 15 (3) 359-366; DOI: https://doi.org/10.2215/CJN.11710919

Add to Selected Citations
You have accessRestricted Access
Sodium Bicarbonate Supplementation and Urinary TGF-β1 in Nonacidotic Diabetic Kidney Disease
Kalani L. Raphael, Tom Greene, Guo Wei, Tristin Bullshoe, Kunani Tuttle, Alfred K. Cheung and Srinivasan Beddhu

CJASN February 2020, 15 (2) 200-208; DOI: https://doi.org/10.2215/CJN.06600619

Add to Selected Citations
Open Access
Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria
Sadayoshi Ito, Kenichi Shikata, Masaomi Nangaku, Yasuyuki Okuda and Tomoko Sawanobori

CJASN August 2019, 14 (8) 1161-1172; DOI: https://doi.org/10.2215/CJN.14751218

Add to Selected Citations
You have accessRestricted Access
Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes
Toshiaki Ohkuma, Min Jun, John Chalmers, Mark E. Cooper, Pavel Hamet, Stephen Harrap, Sophia Zoungas, Vlado Perkovic, Mark Woodward and on behalf of the ADVANCE Collaborative Group

CJASN June 2019, 14 (6) 862-872; DOI: https://doi.org/10.2215/CJN.13391118

Add to Selected Citations
You have accessRestricted Access
Early Glomerular Hyperfiltration and Long-Term Kidney Outcomes in Type 1 Diabetes
Mark E. Molitch, Xiaoyu Gao, Ionut Bebu, Ian H. de Boer, John Lachin, Andrew Paterson, Bruce Perkins, Amy K. Saenger, Michael Steffes, Bernard Zinman and for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group

CJASN June 2019, 14 (6) 854-861; DOI: https://doi.org/10.2215/CJN.14831218

Add to Selected Citations
You have accessRestricted Access
Hypoglycemia in People with Type 2 Diabetes and CKD
Iram Ahmad, Leila R. Zelnick, Zona Batacchi, Nicole Robinson, Ashveena Dighe, Jo-Anne E. Manski-Nankervis, John Furler, David N. O’Neal, Randie Little, Dace Trence, Irl B. Hirsch, Nisha Bansal and Ian H. de Boer

CJASN June 2019, 14 (6) 844-853; DOI: https://doi.org/10.2215/CJN.11650918

Add to Selected Citations
Open Access
Efficacy and Safety of Imarikiren in Patients with Type 2 Diabetes and Microalbuminuria
Sadayoshi Ito, Tomoya Kagawa, Takuya Saiki, Kohei Shimizu, Shingo Kuroda, Yuhei Sano and Yuusuke Umeda

CJASN March 2019, 14 (3) 354-363; DOI: https://doi.org/10.2215/CJN.07720618

Add to Selected Citations
You have accessRestricted Access
Effects of Dapagliflozin on Circulating Markers of Phosphate Homeostasis
Maarten A. de Jong, Sergei I. Petrykiv, Gozewijn D. Laverman, Antonius E. van Herwaarden, Dick de Zeeuw, Stephan J.L. Bakker, Hiddo J.L. Heerspink and Martin H. de Borst

CJASN January 2019, 14 (1) 66-73; DOI: https://doi.org/10.2215/CJN.04530418

Add to Selected Citations
You have accessRestricted Access
Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD
Sankar D. Navaneethan, Julia M. Akeroyd, David Ramsey, Sarah T. Ahmed, Shiva Raj Mishra, Laura A. Petersen, Paul Muntner, Christie Ballantyne, Wolfgang C. Winkelmayer, Venkat Ramanathan and Salim S. Virani

CJASN December 2018, 13 (12) 1842-1850; DOI: https://doi.org/10.2215/CJN.03830318

Add to Selected Citations
You have accessRestricted Access
Long-Term Effects of Intensive Glycemic and Blood Pressure Control and Fenofibrate Use on Kidney Outcomes
Amy K. Mottl, John B. Buse, Faramarz Ismail-Beigi, Ronald J. Sigal, Carolyn F. Pedley, Vasilios Papademetriou, Debra L. Simmons, Lois Katz, Josyf C. Mychaleckyj and Timothy E. Craven

CJASN November 2018, 13 (11) 1693-1702; DOI: https://doi.org/10.2215/CJN.06200518

Add to Selected Citations

Main menu

User menu

Search

More articles from Diabetes and the Kidney

Pages

About

Author Information

More information